Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STA-1 Add-on to Donepezil in Mild to Moderate Alzheimer's Disease
NCT01255046Phase 2Unknown
- Sponsor
- Sinphar Pharmaceutical
- Start
- Dec 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of STA-1 in Alzheimer's disease (AD), sponsored by Sinphar Pharmaceutical. Status: unknown.
02
Drugs
STA-1
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01255046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01255046.